Vertex Pharmaceuticals Insider Trades

VRTX

Vertex Pharmaceuticals (VRTX) is a global biopharmaceutical company renowned for developing transformative medicines for serious diseases, particularly in areas like cystic fibrosis, sickle cell disease, and beta thalassemia. The company's leadership includes key figures such as Executive Chairman Dr. Jeffrey Leiden and President and CEO Dr. Reshma Kewalramani. Tracking insider trading activity from Vertex Pharmaceuticals' executives and directors can offer insights into their perspectives on the company's future performance and ongoing advancements in its diverse pipeline of innovative therapies.

Trades Last 12 Months

VRTX Price

All Insider Trades for Vertex Pharmaceuticals

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $445k 795 shares
Last Trade
Oct 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 795 shares
$503.47
$559.41
Garber Alan M Director
Holding Value $52.6k 94 shares
Last Trade
Oct 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.8k 29 shares
$508.75
$559.41
Sachs Bruce I Director
Holding Value $8.87M 15,864 shares
Last Trade
Oct 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.8k 92 shares
$508.75
$559.41
Van Grunsven Jasper Evp, CP And NPPO
Holding Value $4.86M 8,682 shares
Last Trade
Sep 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.59M 8,682 shares
$528.90
$559.41
Ambrose Kristen SVP & Chief Accounting Officer
Holding Value $6.5M 11,624 shares
Last Trade
Aug 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.71M 5,000 shares
$541.69
$559.41
Tatsis Ourania Evp, Chief Reg. & Quality Off.
Holding Value $30M 53,572 shares
Last Trade
Jul 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.01M 8,251 shares
$485.65
$559.41
Sachdev Amit EVP Chief Patient & Ext Af Off
Holding Value $37.2M 66,512 shares
Last Trade
Jul 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.01M 8,251 shares
$485.65
$559.41
Mc Kechnie Duncan Evp, Chief Commercial Officer
Holding Value $6.15M 11,001 shares
Last Trade
Jul 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$800k 1,541 shares
$519.00
$559.41
Liu Joy EVP And Chief Legal Officer
Holding Value $10.7M 19,131 shares
Last Trade
Jul 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$416k 828 shares
$502.71
$559.41
Bozic Carmen EVP And CMO
Holding Value $8.58M 15,337 shares
Last Trade
Jun 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$288k 596 shares
$482.50
$559.41
Bunnage Mark E. Evp, Chief Scientific Officer
Holding Value $4.07M 7,284 shares
Last Trade
May 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$15k 33 shares
$453.45
$559.41
Holding Value $2.75M 4,924 shares
Last Trade
May 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$135k 318 shares
$423.73
$559.41
Lagarde Michel Director
Holding Value $1.6M 2,866 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 2,866 shares
$424.45
$559.41
Holding Value $1.23M 2,190 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.15M 2,701 shares
$423.92
$559.41
Thornberry Nancy Director
Holding Value $1.18M 2,109 shares
Last Trade
May 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$169k 398 shares
$423.92
$559.41
Mckenzie Diana Director
Holding Value $4.36M 7,787 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$337k 796 shares
$423.92
$559.41
Sachs Bruce I Director
Holding Value $1.6M 2,866 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 2,866 shares
$424.45
$559.41
Carney Lloyd Director
Holding Value $1.6M 2,866 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 2,866 shares
$424.45
$559.41
Upadhyay Suketu Director
Holding Value $872k 1,558 shares
Last Trade
May 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$337k 796 shares
$423.92
$559.41
Mc Kechnie Duncan Evp, Chief Commercial Officer
Holding Value $6.99M 12,489 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.31M 2,633 shares
$498.42
$559.41

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up